Skip to content
Clinical Trials – home
Verifiedinfo

Centre de Radiothérapie Guillaume le Conquérant

France 61 Rue Denfert Rochereau, 76600 Le Havre, France

  • 5 trials recruiting
  • Squamous cell carcinoma of head and neck · Rectal cancer · Microsatellite instability cancer
  • Adult patients

About Specializations

Centre de Radiothérapie Guillaume le Conquérant in Le Havre, France specialises in clinical trials of conditions such as Squamous cell carcinoma of head and neck, Rectal cancer, Microsatellite instability cancer, Mismatch repair cancer syndrome, and other specialisations. This site conducts important research.

Main research areas of the site

Neuro-Oncology

The medical center is at the forefront of neuro-oncology, focusing on innovative treatments for complex conditions such as brain metastases and brain radionecrosis. The center's research is pivotal in exploring advanced therapeutic options to improve patient outcomes.

  • Brain Metastases Management
  • Radionecrosis Treatment
  • Neurological Symptom Alleviation

Through rigorous clinical trials, the center is investigating the efficacy of combining bevacizumab with standard corticosteroid therapy, aiming to enhance the quality of life for patients suffering from these challenging conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
61 Rue Denfert Rochereau76600 Le HavreFrance
Recruiting now
5 trials
Conditions studied
9
Partner status
Verified

More sites in Le HavreFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

12 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ivonescimab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Institut De Cancerologie De L Ouest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:PUCOTENLIMAB
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.